Page last updated: 2024-12-11
3'-methoxypuerarin
Description
3'-methoxypuerarin: inhibits formation of advanced glycation end products; isolated from Pueraria lobata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|
| Pueraria | genus | A plant genus of the family FABACEAE a common weed of the southeast US. There has been folk use for alcoholism and liver protection. It contains puerarin, kakkalide, daidzein (isoflavonoids), and kudzusaponins (oleanene-type triterpene glycosides).[MeSH] | Fabaceae | The large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH] |
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 5319485 |
| CHEMBL ID | 3902210 |
| SCHEMBL ID | 8582185 |
| MeSH ID | M0506899 |
Synonyms (20)
| Synonym |
|---|
| 3'-methoxypuerarin |
| 7-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one |
| SCHEMBL8582185 |
| 117047-07-1 |
| AC-34376 |
| 3-methoxy puerarin |
| Q-100079 |
| (8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-4h-1-benzopyran-4-one) |
| CHEMBL3902210 |
| CS-0018298 |
| HY-N1978 |
| 7-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one |
| AKOS030573599 |
| 3'- methoxy puerarin |
| 3 inverted exclamation mark - methoxy puerarin |
| puerariaglycoside 3 |
| 3 inverted exclamation mark -methoxy puerarin |
| MS-28051 |
| PD100425 |
| 3invertedexclamationmark-methoxypuerarin |
Research Excerpts
Pharmacokinetics
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.36 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.44 (4.65) | | Search Engine Demand Index | 10.37 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |